362 related articles for article (PubMed ID: 31202946)
1. Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement.
Jochheim D; Barbanti M; Capretti G; Stefanini GG; Hapfelmeier A; Zadrozny M; Baquet M; Fischer J; Theiss H; Todaro D; Chieffo A; Presbitero P; Colombo A; Massberg S; Tamburino C; Mehilli J
JACC Cardiovasc Interv; 2019 Aug; 12(16):1566-1576. PubMed ID: 31202946
[TBL] [Abstract][Full Text] [Related]
2. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB
JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338
[TBL] [Abstract][Full Text] [Related]
4. Non-vitamin K oral anticoagulants versus vitamin K antagonists in post transcatheter aortic valve replacement patients with clinical indication for oral anticoagulation: A meta-analysis.
Chen YF; Liu F; Li XW; Zhang HJ; Liu YG; Lin L
Clin Cardiol; 2022 Apr; 45(4):401-406. PubMed ID: 35191074
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
[TBL] [Abstract][Full Text] [Related]
6. Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
Tanawuttiwat T; Stebbins A; Marquis-Gravel G; Vemulapalli S; Kosinski AS; Cheng A
J Am Heart Assoc; 2022 Jan; 11(1):e023561. PubMed ID: 34970918
[TBL] [Abstract][Full Text] [Related]
7. Non-Vitamin K Antagonist Versus Vitamin K Antagonist Oral Anticoagulant Agents After Transcatheter Aortic Valve Replacement.
Alaour B; Ferrari E; Heg D; Tueller D; Pilgrim T; Muller O; Noble S; Jeger R; Reuthebuch O; Toggweiler S; Templin C; Wenaweser P; Nietlispach F; Taramasso M; Huber C; Roffi M; Windecker S; Stortecky S
JACC Cardiovasc Interv; 2024 Feb; 17(3):405-418. PubMed ID: 38355269
[TBL] [Abstract][Full Text] [Related]
8. Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF Trial.
Hengstenberg C; Van Mieghem NM; Wang R; Ye X; Shi L; Guo S; Chen C; Jin J; Ye X; Dangas G; Unverdorben M
Am J Cardiol; 2023 Dec; 209():212-219. PubMed ID: 37848174
[TBL] [Abstract][Full Text] [Related]
9. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
[TBL] [Abstract][Full Text] [Related]
11. Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
Sherwood MW; Gupta A; Vemulapalli S; Li Z; Piccini J; Harrison JK; Dai D; Vora AN; Mack MJ; Holmes DR; Rumsfeld JS; Cohen DJ; Thourani VH; Kirtane AJ; Peterson ED
Circ Cardiovasc Interv; 2021 Apr; 14(4):e009963. PubMed ID: 33877866
[TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
Memon MM; Siddiqui AA; Amin E; Shaikh FN; Khan MS; Doukky R; Krasuski RA
Catheter Cardiovasc Interv; 2022 Jun; 99(7):2101-2110. PubMed ID: 35476221
[TBL] [Abstract][Full Text] [Related]
13. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V;
J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096
[TBL] [Abstract][Full Text] [Related]
14. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR.
Kawashima H; Watanabe Y; Hioki H; Kozuma K; Kataoka A; Nakashima M; Nagura F; Nara Y; Yashima F; Tada N; Naganuma T; Yamawaki M; Yamanaka F; Shirai S; Mizutani K; Tabata M; Ueno H; Takagi K; Yamamoto M; Hayashida K;
JACC Cardiovasc Interv; 2020 Nov; 13(22):2587-2597. PubMed ID: 33129818
[TBL] [Abstract][Full Text] [Related]
15. Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
JACC Cardiovasc Interv; 2017 Jan; 10(1):66-74. PubMed ID: 27916486
[TBL] [Abstract][Full Text] [Related]
16. Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patients - A Subanalysis of the ENVISAGE-TAVI AF Trial.
Watanabe Y; Hayashida K; Yamamoto M; Yamanaka F; Yamasaki K; Naganuma T; Ohno Y; Yamawaki M; Morioka N; Mizutani K; Tada N; Ueno H; Nishina H; Izumo M; Nakajima Y; Ando K; Takagi K; Kimura T; Sugio K; Dangas G; Van Mieghem NM; Hengstenberg C; Chen C; Jin J; Unverdorben M; Saito S
Circ J; 2022 Oct; 86(11):1756-1763. PubMed ID: 35965066
[TBL] [Abstract][Full Text] [Related]
17. Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis.
Lee WC; Shih JY; Fang HY; Wu PJ; Fang CY; Chen HC; Fang YN; Chang WT; Chen MC
Clin Appl Thromb Hemost; 2023; 29():10760296231158585. PubMed ID: 36815218
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
19. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
[TBL] [Abstract][Full Text] [Related]
20. TAVR Patients Requiring Anticoagulation: Direct Oral Anticoagulant or Vitamin K Antagonist?
Didier R; Lhermusier T; Auffret V; Eltchaninoff H; Le Breton H; Cayla G; Commeau P; Collet JP; Cuisset T; Dumonteil N; Verhoye JP; Beurtheret S; Lefèvre T; Teiger E; Carrié D; Himbert D; Albat B; Cribier A; Sudre A; Blanchard D; Bar O; Rioufol G; Collet F; Houel R; Labrousse L; Meneveau N; Ghostine S; Manigold T; Guyon P; Delepine S; Favereau X; Souteyrand G; Ohlmann P; Doisy V; Beygui F; Gommeaux A; Claudel JP; Bourlon F; Bertrand B; Iung B; Gilard M;
JACC Cardiovasc Interv; 2021 Aug; 14(15):1704-1713. PubMed ID: 34274294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
